Pharma

3,414 Followers

Robert McGrathadded this to Prostate Cancer
Metastasis
With safety data, Bayer could challenge Erleada, Xtandi in prostate cancer: analyst
fiercepharma.com
For years, Johnson & Johnson and the Pfizer-Astellas team have been the only players in their class of prostate-cancer fighters. But Bayer is waiting …
Jayadded this to This World
Science
In Hindsight Maybe This Pro-Fentanyl Rap Video Made by a Pharma Company Wasn't the Best Look
Gizmodo - Ed Cara
That drug companies have fueled the opioid crisis by flooding the market with deceptively marketed, highly addictive painkillers is no secret. But …
Jezebel
Breast Cancer
Big Pharma Is Into Instagram Sponcon Now
Jezebel - Prachi Gupta
The new frontier of SponCon is, unfortunately, looking at manicured photos of hot people and their hot lives interspersed with content paid for by …
Eli Lilly
Pharma raises prices to ring in 2019. Will it trigger action in Washington?
fiercepharma.com - www.fiercepharma.com
Allergan jacked up the stickers on seven drugs by 9.5% to start 2019, according to a note from Evercore ISI analyst Umer Raffat. Also hiking certain …
Investing.com Indiaadded this to STOCK MARKETS
BRIEF-Sun Pharma Advanced Research Says Sun Pharma Global FZE Plans To Not Launch Elepsiatm XR
investing.com
Feb 15 (Reuters) - Sun Pharma (NS:SUN) Advanced Research Company Ltd SPRC.NS : * SUN PHARMA ADVANCED RESEARCH COMPANY LTD - RECEIVED COMMUNICATION …
Axiosadded this to Axios
Rand Paul
Big Pharma's GOP firewall is weakening, as Republicans consider more action
Axios - Caitlin Owens
Congressional Republicans are increasingly open to cracking down on the tactics pharmaceutical companies use to keep competition at bay — changes …
The Washington Post
Health Care
Drug Giants Can Save America Billions. But Will They?
The Washington Post - By Max Nisen | Bloomberg
Pharma and its drug-pricing practices have come under fire from critics on the right and left, and from lawmakers on Capitol Hill to Donald Trump’s White House. But amid the political bashing, here’s that
Cancer
Merck aims for prostate cancer dominance with 3 new phase 3 Keytruda studies
fiercepharma.com - www.fiercepharma.com
If Merck & Co. gets its way, it won’t be long before the prostate cancer treatment landscape looks pretty different. After fielding promising early …
dan hadded this to PICKS OF THE DAY
Former pharmacist fined and given conditional sentence
ctvnews.ca - Michael Franklin
A Calgary woman who forged information in order to acquire prescription drugs from the pharmacy where she worked was sentenced on Wednesday. Leanne …
Opioids
Pharmaceutical Company Makes Rap Video Pushing Doctors To Prescribe Opioids
iheart.com - 1065.iheart.com
There's an opioid crisis happening. The founder of a huge pharmaceutical company is on trial. Just surfaced: a rap video about the good side of …
Markets Insideradded this to Markets Insider
The City
ADVANZ PHARMA Corp. -- Moody's announces completion of a periodic review of ratings of ADVANZ PHARMA Corp.
Business Insider - Moodys
Announcement: Moody's announces completion of a periodic review of ratings of ADVANZ PHARMA Corp. Read the full article at Moody's
Caixin Globaladded this to Caixin Daily News
News (China)
Pharmaceutical Firm Avoids Default as Guangdong Pressures Customers
caixinglobal.com
An embattled Chinese pharmaceutical company on the verge of defaulting on almost $300 million of bonds was able to retire the debt thanks to pressure …
Terrorism
AMU student from Kashmir booked for objectionable tweet on Pulwama Terror Attack
opindia.com - OpIndia Staff
--- Read the article [AMU student from Kashmir booked for objectionable tweet on Pulwama Terror Attack] on OpIndia website --- An FIR has been …
The Wall Street Journal.
Fake News
Insurers’ Lobby Puts Drug Price Blame on Pharma
The Wall Street Journal. - The Wall Street Journal
Casting blame for high drug prices on insurance providers, pharmacy-benefit managers or others is the definition of fake news. Regarding Adam J. Fein’s “Don’t Blame Drug Prices on ‘Big Pharma’” (op-ed,
Armed Men Attack Indian Pharmaceutical Executive in Moscow
themoscowtimes.com
An Indian national who heads a pharmaceutical company in Russia has been reportedly hospitalized after falling victim to an armed attack in …
National Postadded this to Full Comment
Opinion (Canada)
Robert Fulford: An OxyContin protest at the Met might change the charity game
nationalpost.com - Robert Fulford
Last weekend in New York a crowd of artists and their friends stormed the stately front steps of the Metropolitan Museum of Art to express a serious …
Alzheimer's Disease
Development of Pharmaceutical Agent For The Treatment of Diabetes & Obesity
eurekalert.org - www.eurekalert.org
This book is Edited by: Atta-ur-Rahman, published on: January 18, 2019 Pharmacologic Obesity Treatment Interplay Between Bile Acid and GLP-1 Receptor …
Peak Bggradded this to Marijuana Investing
Cannabinoids
Pivot Pharma develops transdermal patch
Seeking Alpha - Mamta Mayani
Pivot Pharmaceuticals (OTCQB:PVOTF) has completed the development of a controlled-release transdermal patch system for the delivery of cannabinoids. …
Dr. Reddy's racks up more repeat violations at Bachupally formulations plant
fiercepharma.com - Eric Palmer
Dr. Reddy’s, which has been struggling to bring a number of its key plants up to FDA standards, has been unable to learn from past mistakes, …
Eli Lilly
Lilly asks migraine patients to use their imaginations in first DTC push for Emgality
fiercepharma.com - www.fiercepharma.com
Eli Lilly’s first effort for migraine drug Emgality had a personal connection for the director of the TV commercial. Robert Stromberg, who has worked …
Outlook Magazineadded this to Outlook India
Ophthalmology
Alembic Pharma gets USFDA nod for ophthalmic solution
outlookindia.com
New Delhi, Feb 15 Drug firm Alembic Pharmaceuticals Friday said it has received approval from the US health regulator for Moxifloxacin Ophthalmic …
Rabies
Bharat buys GSK’s Indian vaccine unit to become largest rabies shot producer
fiercepharma.com - Angus Liu
After casting off its Indian consumer health franchise, GlaxoSmithKline is selling its Chiron Behring Vaccines unit in India to Bharat Biotech. The …
Martin Shkreli
Egalet's 70% price increase shows the buy-and-hike strategy is alive and well
fiercepharma.com - Eric Sagonowsky
While Big Pharma's price increases these days are in the single digits—and still triggering Twitter outrage—some small companies aren't shying away …
Valsartan
FiercePharmaAsia—AstraZeneca’s China business; Pfizer Japan valsartan recall; Xofluza resistance
fiercepharma.com - Angus Liu
AstraZeneca's China business soared 25% in 2018 as cancer and respiratory drugs pulled through; Pfizer Japan is recalling valsartan combo drugs made …
Breast Cancer
Swayed by discounts, NICE finally backs Roche's Perjeta for post-surgery breast cancer
fiercepharma.com - Carly Helfand
Looks like the third time was a charm for Roche’s Perjeta when it comes to stepped-up use in England. Thanks to new discounts, the cost-effectiveness …
Elechi NC Wisdom Wineenblackadded this to Health
New Jersey
FDA uncovers data manipulation at Immunomedics plant making cancer drug
fiercepharma.com
Immunomedics received an FDA complete response letter last month tied to manufacturing concerns about its breast cancer antibody-drug conjugate. When …
Seeking Alpha
West Pharmaceutical beats by $0.01, misses on revenue
Seeking Alpha - Vandana Singh
West Pharmaceutical (NYSE:WST): Q4 Non-GAAP EPS of $0.73 beats by $0.01; GAAP EPS of $0.69 misses by $0.02. Revenue of $422.5M (+1.7% Y/Y) misses by …
The Motley Fool
FDA
Here's Why CorMedix Dropped as Much as 27.1% Today
The Motley Fool - Maxx Chatsko
The company announced an update after meeting the FDA. What happened Shares of CorMedix (NYSEMKT:CRMD) dropped over 27% after the company provided an …
Nova Scotia
Cape Breton pharmacist loses licence to practise
cbc.ca - Wendy Martin
A Cape Breton pharmacist no longer has a licence to practise. The Nova Scotia College of Pharmacists revoked the licence of Shelley Ross in a decision …
Seeking Alpha
Agios Pharma Q4 top line up 206%
Seeking Alpha - Mamta Mayani
Agios Pharmaceuticals (AGIO +8.2%) Q4 results: Revenues: $30M (+206.1%); Product revenue: $9.4M; Party related collaboration revenue: $18.2M …